{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:37:41Z","timestamp":1694417861276},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1007\/s11936-002-0039-8","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T06:12:33Z","timestamp":1181196753000},"page":"443-453","source":"Crossref","is-referenced-by-count":6,"title":["Hypertrophic Cardiomyopathy"],"prefix":"10.1007","volume":"4","author":[{"given":"Elijah R.","family":"Behr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"39_CR1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.56.2.292","volume":"56","author":"BH Bulkley","year":"1977","unstructured":"Bulkley BH, Weisfeldt ML, Hutchins GM: Asymmetric septal hypertrophy and myocardial fiber disarray. Features of normal, developing, and malformed hearts. Circulation 1977, 56:292\u2013298.","journal-title":"Circulation"},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/hrt.51.4.361","volume":"51","author":"MJ Davies","year":"1984","unstructured":"Davies MJ: The current status of myocardial disarray in hypertrophic cardiomyopathy [editorial]. Br Heart J 1984, 51:361\u2013363.","journal-title":"Br Heart J"},{"key":"39_CR3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.CIR.59.4.689","volume":"59","author":"BJ Maron","year":"1979","unstructured":"Maron BJ, Roberts WC: Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 1979, 59:689\u2013706.","journal-title":"Circulation"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M, et al.: Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies [news]. Circulation 1996, 93:841\u2013842.","journal-title":"Circulation"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","volume":"80","author":"MB Codd","year":"1989","unstructured":"Codd MB, Sugrue DD, Gersh BJ, Melton LJ: Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975\u20131984. Circulation 1989, 80:564\u2013572.","journal-title":"Circulation"},{"key":"39_CR6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM, et al.: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995, 92:785\u2013789.","journal-title":"Circulation"},{"key":"39_CR7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/heart.87.2.169","volume":"87","author":"WJ McKenna","year":"2002","unstructured":"McKenna WJ, Behr ER: Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart 2002, 87:169\u2013176.","journal-title":"Heart"},{"key":"39_CR8","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","volume":"36","author":"PM Elliott","year":"2000","unstructured":"Elliott PM, Poloniecki J, Dickie S, et al.: Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000, 36:2212\u20132218. This paper provides a prospective analysis of outcomes in a large cohort of HCM patients. It indicates factors associated with increased risk of sudden death and provides a statistical basis for determining individual risk and the need for treatment.","journal-title":"J Am Coll Cardiol"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0735-1097(95)00353-3","volume":"26","author":"F Cecchi","year":"1995","unstructured":"Cecchi F, Olivotto I, Montereggi A, et al.: Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995, 26:1529\u20131536.","journal-title":"J Am Coll Cardiol"},{"key":"39_CR10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","volume":"281","author":"BJ Maron","year":"1999","unstructured":"Maron BJ, Casey SA, Poliac LC, et al.: Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999, 281:650\u2013655. [Published erratum appears in JAMA 1999, 281:2288.]","journal-title":"JAMA"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","volume":"342","author":"BJ Maron","year":"2000","unstructured":"Maron BJ, Shen WK, Link MS, et al.: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000, 342:365\u2013373. This registry data deals with the largest cohort of HCM patients with ICDs and provides justification of device therapy as well as cautionary messages on the risks of interventions.","journal-title":"N Engl J Med"},{"key":"39_CR12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0735-1097(86)80484-3","volume":"7","author":"WJ Stafford","year":"1986","unstructured":"Stafford WJ, Trohman RG, Bilsker M, et al.: Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986, 7:701\u2013704.","journal-title":"J Am Coll Cardiol"},{"key":"39_CR13","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","volume":"104","author":"I Olivotto","year":"2001","unstructured":"Olivotto I, Cecchi F, Casey SA, et al.: Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001, 104:2517\u20132524.","journal-title":"Circulation"},{"key":"39_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0002-9149(87)90998-2","volume":"60","author":"P Spirito","year":"1987","unstructured":"Spirito P, Maron BJ, Bonow RO, Epstein SE: Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 1987, 60:123\u2013129.","journal-title":"Am J Cardiol"},{"key":"39_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/heart.83.3.255","volume":"83","author":"CJ Knight","year":"2000","unstructured":"Knight CJ: Five years of percutaneous transluminal septal myocardial ablation. Heart 2000, 83:255\u2013256.","journal-title":"Heart"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/s-2007-1013118","volume":"47","author":"H Seggewiss","year":"1999","unstructured":"SeggewissH, Faber L, Gleichmann U: Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg 1999, 47:94\u2013100. This study reports on the largest series of patients undergoing septal alcohol ablation, and it supports the safety and efficacy of the procedure.","journal-title":"Thorac Cardiovasc Surg"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0735-1097(96)00473-1","volume":"29","author":"RA Nishimura","year":"1997","unstructured":"Nishimura RA, Trusty JM, Hayes DL, et al.: Dualchamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997, 29:435\u2013441.","journal-title":"J Am Coll Cardiol"},{"key":"39_CR18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.CIR.94.3.467","volume":"94","author":"RB McCully","year":"1996","unstructured":"McCully RB, Nishimura RA, Tajik AJ, et al.: Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996, 94:467\u2013471.","journal-title":"Circulation"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0002-9149(84)80212-X","volume":"54","author":"WJ McKenna","year":"1984","unstructured":"McKenna WJ, Harris L, Rowland E, et al.: Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol 1984, 54:802\u2013810.","journal-title":"Am J Cardiol"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.CIR.80.5.1259","volume":"80","author":"L Fananapazir","year":"1989","unstructured":"Fananapazir L, Tracy CM, Leon MB, et al.: Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 1989, 80:1259\u20131268.","journal-title":"Circulation"},{"key":"39_CR21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/hrt.53.4.412","volume":"53","author":"WJ McKenna","year":"1985","unstructured":"McKenna WJ, Oakley CM, Krikler DM, Goodwin JF: Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985, 53:412\u2013416.","journal-title":"Br Heart J"},{"key":"39_CR22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM198805123181907","volume":"318","author":"P Nicod","year":"1988","unstructured":"Nicod P, Polikar R, Peterson KL: Hypertrophic cardiomyopathy and sudden death. N Engl J Med 1988, 318:1255\u20131257.","journal-title":"N Engl J Med"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.CIR.62.2.218","volume":"62","author":"BJ Maron","year":"1980","unstructured":"Maron BJ, Roberts WC, McAllister HA, et al.: Sudden death in young athletes. Circulation 1980, 62:218\u2013229.","journal-title":"Circulation"},{"key":"39_CR24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1056\/NEJM198704023161405","volume":"316","author":"BJ Maron","year":"1987","unstructured":"Maron BJ, Bonow RO, Cannon RO, et al.: Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med 1987, 316:844\u2013852.","journal-title":"N Engl J Med"},{"key":"39_CR25","first-page":"775","volume-title":"Comprehensive Cardiovascular Medicine","author":"W McKenna","year":"1998","unstructured":"McKenna W, Elliott PM: Hypertrophic cardiomyopathy. In Comprehensive Cardiovascular Medicine. Edited by Topol EJ. Philadelphia, PA: Lipincott-Raven;1998:775\u2013798."},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9149(88)90268-8","volume":"62","author":"C Pollick","year":"1988","unstructured":"Pollick C, Kimball B, Henderson M, Wigle ED: Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration. Am J Cardiol 1988, 62:1248\u20131251.","journal-title":"Am J Cardiol"},{"key":"39_CR27","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/0002-9149(88)90269-X","volume":"62","author":"C Pollick","year":"1988","unstructured":"Pollick C: Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration. Am J Cardiol 1988, 62:1252\u20131255.","journal-title":"Am J Cardiol"},{"key":"39_CR28","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM198210143071607","volume":"307","author":"C Pollick","year":"1982","unstructured":"Pollick C: Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide. N Engl J Med 1982, 307:997\u2013999.","journal-title":"N Engl J Med"},{"key":"39_CR29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(94)91895-3","volume":"344","author":"HC Doval","year":"1994","unstructured":"Doval HC, Nul DR, Grancelli HO, et al.: Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994, 344:493\u2013498.","journal-title":"Lancet"},{"key":"39_CR30","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","volume":"99","author":"BJ Maron","year":"1999","unstructured":"Maron BJ, Nishimura RA, McKenna WJ, et al.: Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, crossover study (M-PATHY). Circulation 1999, 99:2927\u20132933.","journal-title":"Circulation"},{"key":"39_CR31","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(99)00056-X","volume":"33","author":"PM Elliott","year":"1999","unstructured":"Elliott PM, Sharma S, Varnava A, et al.: Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999, 33:1596\u20131601.","journal-title":"J Am Coll Cardiol"},{"key":"39_CR32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0003-4975(97)01434-3","volume":"65","author":"WR Wilson","year":"1998","unstructured":"Wilson WR, Greer GE, Grubb BP: Implantable cardioverter-defibrillators in children: a single-institutional experience. Ann Thorac Surg 1998, 65:775\u2013778.","journal-title":"Ann Thorac Surg"},{"key":"39_CR33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-5223(96)70310-0","volume":"111","author":"RC Robbins","year":"1996","unstructured":"Robbins RC, Stinson EB: Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996, 111:586\u2013594.","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-002-0039-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-002-0039-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-002-0039-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:52:28Z","timestamp":1559436748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-002-0039-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s11936-002-0039-8","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}